During the past decade, Kansas City Heart Foundation conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kansas City Heart Foundation" #1 sponsor was "Atrium Medical Corporation" with 1 trials, followed by "Baim Institute for Clinical Research" with 1 trials sponsored, "Biotronik, Inc." with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "Iverson Genetic Diagnostics, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kansas City Heart Foundation" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Cordis Corporation" with 1 trials as a collaborator and "Daiichi Sankyo, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Kansas City Heart Foundation" are "Heart Failure" (2 trials), "Anti-coagulation Therapy" (1 trials), "Atrial Fibrillation" (1 trials), "CRT-D Cardiac Resynchronization Therapy Defibrillator" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Kansas City Heart Foundation" in a lesser frequency.

Most popular intervention types in "Kansas City Heart Foundation" are "Device" (3 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Clopidogrel & Aspirin, Prasugrel & Aspirin" (1 trials), "Implantable Cardioverter Defibrillator with Cardiac Resynchronization Therapy (BIOTRONIK Lumax HF-T CRT-D)" (1 trials), "Placebo & Aspirin" (1 trials), "Ranolazine" (1 trials) and "Warfarin GenoSTAT Test" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kansas City Heart Foundation" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Kansas City Heart Foundation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Kansas City Heart Foundation, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kansas City Heart Foundation, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".